Synaptic impairment in AD is driven by toxic oligomers of amyloid beta (oAβ)1 and tau (oTau),2 which disrupt actin cytoskeletal dynamics, resulting in synaptic dysfunction and degeneration.3 This evidence concerns the gene MAPT and Alzheimer disease.